» Articles » PMID: 16216999

Racial Disparities in Hypertension Prevalence, Awareness, and Management

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 2005 Oct 12
PMID 16216999
Citations 221
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Effectively reducing cardiovascular disease disparities requires identifying and reducing disparities in risk factors. Improved understanding of hypertension disparities is critical.

Methods: Cross-sectional analysis of nationally representative samples of black and white adults 20 years and older who participated in the National Health and Nutrition Examination Survey (NHANES) 1999-2002 (white, n = 4624; black, n = 1837) and NHANES III conducted in 1988-1994 (white, n = 7121; black, n = 4709). We examined differences in hypertension prevalence, awareness, treatment, and blood pressure (BP) control among both treated and prevalent cases across the 2 periods.

Results: Hypertension prevalence increased significantly from 35.8% to 41.4% among blacks and from 24.3% to 28.1% among whites and remains significantly higher among blacks. Awareness is higher among blacks (77.7% vs 70.4%; P<.001), as is treatment (68.2% vs 60.4%; P<.001). These results are driven by higher rates in black women. Blood pressure control rates among those treated have increased in both races, primarily as a result of increased BP control in black and white men (27.3% and 44.7%, respectively; P<or=.03). Despite the improved BP control rates, disparity in BP control among treated cases increased, with 59.7% of treated whites and 48.9% of treated blacks now reaching BP goal (P<.001). Racial differences in BP control rates among those treated cannot be explained by nonpharmacologic management or health insurance, but educational attainment is associated with BP control.

Conclusion: The higher prevalence of hypertension in blacks and the growing disparity in BP control among those treated pharmacologically are causes for concern.

Citing Articles

Is late-life vulnerability to cardiovascular disease risk associated with longitudinal tau accumulation in older adults with mild cognitive impairment?.

Dratva M, Diaz J, Thomas M, Shen Q, Tsiknia A, Rostowsky K JAR Life. 2025; 14:100001.

PMID: 40046641 PMC: 11879684. DOI: 10.1016/j.jarlif.2025.100001.


Accounting for racial bias and social determinants of health in a model of hypertension control.

Hu Y, Cordella N, Mishuris R, Paschalidis I BMC Med Inform Decis Mak. 2025; 25(1):53.

PMID: 39901187 PMC: 11792567. DOI: 10.1186/s12911-025-02873-4.


Disparities in Clinical Outcomes Observed Within Electronic Health Record Data From a Statewide Cohort of Pulmonary Arterial Hypertension Patients.

Dalton R, Desai A, Jiao T, Duarte J Pulm Circ. 2025; 15(1):e70041.

PMID: 39811577 PMC: 11729391. DOI: 10.1002/pul2.70041.


Malignant hypertension: current challenges, prevention strategies, and future perspectives.

Tsige A, Ayele S Front Cardiovasc Med. 2025; 11():1409212.

PMID: 39776865 PMC: 11703975. DOI: 10.3389/fcvm.2024.1409212.


Assessment of musical interventions and its effect on blood pressure among United States populations: a systematic review and meta-analysis.

Meda S, Gyamfi J, Patel K, Islam F, Vieira D, Nyame S Front Cardiovasc Med. 2024; 11:1405455.

PMID: 39473892 PMC: 11519815. DOI: 10.3389/fcvm.2024.1405455.